Compare LNN & IART Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LNN | IART |
|---|---|---|
| Founded | 1954 | 1989 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.2B |
| IPO Year | 1995 | 1996 |
| Metric | LNN | IART |
|---|---|---|
| Price | $116.11 | $16.59 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 7 |
| Target Price | ★ $113.00 | $14.33 |
| AVG Volume (30 Days) | 93.4K | ★ 827.9K |
| Earning Date | 04-02-2026 | 05-05-2026 |
| Dividend Yield | ★ 1.35% | N/A |
| EPS Growth | ★ 12.81 | N/A |
| EPS | ★ 4.22 | N/A |
| Revenue | ★ $676,368,000.00 | N/A |
| Revenue This Year | N/A | $4.39 |
| Revenue Next Year | $4.74 | $3.40 |
| P/E Ratio | $27.53 | ★ N/A |
| Revenue Growth | ★ 11.41 | N/A |
| 52 Week Low | $97.27 | $8.70 |
| 52 Week High | $148.00 | $20.49 |
| Indicator | LNN | IART |
|---|---|---|
| Relative Strength Index (RSI) | 53.27 | 41.16 |
| Support Level | $115.48 | $16.04 |
| Resistance Level | $120.01 | $18.78 |
| Average True Range (ATR) | 3.09 | 0.65 |
| MACD | 0.22 | -0.13 |
| Stochastic Oscillator | 54.57 | 7.10 |
Lindsay Corp provides proprietary water management and road infrastructure products and services. It manufactures and distributes agricultural irrigation equipment through two segments: Irrigation and Infrastructure. The Irrigation segment makes center pivot, lateral move, and hose reel irrigation systems and parts. The Infrastructure segment produces barriers, crash cushions, road marking and safety equipment, and railroad signals. The majority of revenue is from the Irrigation segment. The company operates in the United States and international markets, with the majority of revenue coming from the United States.
Integra Lifesciences Holdings Corp is a New Jersey-based medical equipment company focused on developing products for regenerative therapy, extremity orthopedics, and neurosurgical applications. The firm is organized into two primary segments: Codman specialty surgical and Tissue technologies. Codman Specialty Surgical generates maximum revenue from its segmental operations. Integra serves Europe, Asia Pacific, and the rest of the world whilst it derives key revenue from domestic sales. The company operates in United States, Europe, Asia Pacific, and Rest of the World.